IMS HEALTH To Demonstrate State-Of-The-Art Pharmaceutical Information Solutions At Premier Pharma-Chemical Expo.Business/Health & Science Editors LONDON--(BW HealthWire)--October 16, 2000 The Pulse of an Industry: More Than 15,000 Pharmaceutical Decision-Makers Expected at CPhI Worldwide 2000 and ICSE ICSE International Conference on Software Engineering ICSE Indian Certificate of Secondary Education (India) ICSE International Contract Services Expo ICSE International Classification of Status in Employment 2000 Events in Milan, Italy IMS HEALTH IMS Health (NYSE: RX) is an international consulting and data services company that supplies the pharmaceutical industry with sales data and consulting services. IMS Health was founded in 1954 by Bill Frohlich and David Dubow. (NYSE NYSE See: New York Stock Exchange :RX), the world's leading provider of information solutions to the pharmaceutical and healthcare industries, announced today that it will showcase its latest insights and innovations for pharma-chemical decision-makers at next month's CPhI Worldwide 2000, the premier international exhibition for the pharmaceutical ingredients and intermediates markets. In addition to hands-on demonstrations of IMS HEALTH information solutions during the event -- to be held November 7-9 in Milan, Italy -- IMS HEALTH experts will share their views on the changing face of the global pharma-chemical industry. "With more than 15,000 industry executives expected in Milan, CPhI Worldwide 2000 is a truly global event," said Paul Jenner, group marketing manager, IMS HEALTH Global Services. "It is an ideal venue for featuring the unique IMS HEALTH information solutions that specifically support the pharma-chemical industry, helping companies identify potential market opportunities simply, quickly and efficiently, around the world." Among the solutions to be featured in Milan is IMS HEALTH Generic Planning, which enables pharmaceutical manufacturers and marketers to assess the market potential of generic versions of ethical drugs whose patents will expire expire /ex·pire/ (ek-spi´er) 1. to exhale. 2. to die. ex·pire v. 1. To breathe one's last breath; die. 2. To exhale. during the next decade. Comprehensive prescription drug prescription drug Prescription medication Pharmacology An FDA-approved drug which must, by federal law or regulation, be dispensed only pursuant to a prescription–eg, finished dose form and active ingredients subject to the provisos of the Federal Food, Drug, sales and volume data for major markets is combined with international patent expiration EXPIRATION. Cessation; end. As, the expiration of, a lease, of a contract, or statute. 2. In general, the expiration of a contract puts an end to all the engagements of the parties, except to those which arise from the non- fulfillment of obligations created information, yielding new insights about market opportunities by country, therapy class, and over 500 marketed molecules. In addition, IMS HEALTH will demonstrate enhancements to Pioneer, its powerful database service that helps chemical companies track opportunities for producing pharmaceutical products in markets around the world. The service now profiles more than 12,500 drugs, including 8,500 drugs in active research and development. A source of detailed intelligence on pharmaceuticals in every major market, Pioneer is a mission-critical tool for strategic planners, scientific researchers, market researchers, business development executives and new product planners. IMS HEALTH will also participate in the concurrent International Contract Services Expo 2000 (ICSE), an exhibition for contract service organizations that is being held in the same venue in Milan. "With pharmaceutical companies increasingly eager to outsource work to outside suppliers with highly specialized spe·cial·ize v. spe·cial·ized, spe·cial·iz·ing, spe·cial·iz·es v.intr. 1. To pursue a special activity, occupation, or field of study. 2. skills, ICSE is the perfect forum to meet these players face-to-face," said Jenner. At ICSE, IMS HEALTH will highlight the enhancements and capabilities of LifeCycle, its Web-based comprehensive database reference tool that delivers powerful insights into more than 150,000 drugs through their entire product lifecycle Product lifecycle or product life cycle is the course of a product's sales and profits over time. The five stages of each product lifecycle are product development, introduction, growth, maturity and decline. - from R&D trials to launch to patent expiration. LifeCycle is a convenient, one-stop resource for identifying new business opportunities, developing competitive profiles and analyzing the global drug market by therapeutic class. For additional information about IMS (1) See IP Multimedia Subsystem. (2) (Information Management System) An early IBM hierarchical DBMS for IBM mainframes. IMS was widely implemented throughout the 1970s under MVS and continues to be used under z/OS. HEALTH's participation in the CPhI Worldwide 2000 (stand E546) or ICSE 2000 (stand D65) events, contact Paul Jenner at +44 (0)20 7393 5828. For general information about CPhI and ICSE, visit the organization's Website at: http://www.cphi.com/. IMS HEALTH is the world's leading provider of information solutions to the pharmaceutical and healthcare industries. With $1.1 billion in 1999 revenue, IMS HEALTH operates in more than 100 countries. IMS HEALTH is the largest pharmaceutical manufacturer information partner, with over 40 years' experience in the industry. Key products and services integral to customer day-to-day operations include market research for prescription and over-the-counter pharmaceutical products and sales management Sales Management Role and Goal Importance of sales management is critical for any commercial organization. Expanding business in not possible without increasing sales volumes, and effective sales management goal is to organize sales team work in such a manner that ensures a information to optimize optimize - optimisation sales force productivity. Additional information is available at http://www.imshealth.com. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion